MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea · Delayed Price · Currency is KRW 1,722.00
+19.00 (1.12%)
At close: Aug 29, 2025
MYUNGMOON Pharm co.,Ltd Market Cap
MYUNGMOON Pharm co.,Ltd has a market cap or net worth of 58.60 billion as of September 5, 2025. Its market cap has decreased by -29.38% in one year.
Market Cap
58.60B
Enterprise Value
151.15B
Revenue
190.76B
Ranking
n/a
PE Ratio
48.70
Stock Price
1,722.00
Market Cap Chart
Since July 10, 2008, MYUNGMOON Pharm co.,Ltd's market cap has increased from 35.32B to 58.60B, an increase of 65.93%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 58.60B | -3.63% |
| Dec 30, 2024 | 60.81B | -20.64% |
| Dec 28, 2023 | 76.62B | -21.03% |
| Dec 29, 2022 | 97.02B | -39.32% |
| Dec 30, 2021 | 159.90B | -34.94% |
| Dec 30, 2020 | 245.77B | 106.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.31T |
| Celltrion | 37.23T |
| ALTEOGEN | 25.41T |
| Yuhan | 8,902.27B |
| SK Biopharmaceuticals | 8,551.81B |
| Peptron | 7,070.75B |
| PharmaResearch | 6,545.48B |
| ABL Bio | 5,621.23B |